Pharmacologic Treatments for Dementia and the Risk of Developing Age-Related Macular Degeneration
This cohort study of patients with dementia found no significant associations between memantine or donepezil compared with other dementia medications and the risk of development of AMD. Further research is recommended to examine any possible pathophysiological protective action of memantine and other dementia medications against the development of AMD.
Authors
- Pearse A. Keane (ORCID: https://orcid.org/0000-0002-9239-745X)
- Krishnarajah Nirantharakumar (ORCID: https://orcid.org/0000-0002-6816-1279)
- Jesse Coker
- Wen‐Hwa Lee (ORCID: https://orcid.org/0000-0002-4098-5225)
- Nicola J. Adderley (ORCID: https://orcid.org/0000-0003-0543-3254)
- Alastair Keith Denniston (ORCID: https://orcid.org/0000-0001-7849-0087)
- Jingya Wang (ORCID: https://orcid.org/0000-0003-1498-2693)
- Christina Antza (ORCID: https://orcid.org/0000-0001-5164-7435)
Institutions
- University Hospitals Birmingham NHS Foundation Trust (GB)
- Moorfields Eye Hospital NHS Foundation Trust (GB)
- Health Data Research UK (GB)
- NIHR Birmingham Biomedical Research Centre (GB)
- University College London (GB)
- University of Birmingham (GB)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2024-10-24
- DOI
- https://doi.org/10.1001/jamanetworkopen.2024.41166
- Citations
- 2
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.08
Funders
- Sanofi
- CSL Behring
- Wellcome Trust
- UK Research and Innovation
- Apellis Pharmaceuticals
- National Institute for Health and Care Research
- South Asian Health Foundation
- Vifor Pharma
- Medical Research Council
- European Regional Development Fund